Naldebain
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Naldebain, covering 2017-09-28 to 2025-05-09. Get the full timeline:
Most recent: Clinical Trial Update: Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section [Phase 2, Phase 3]